Search

Author/Creator Ricker, Justin L.

1. Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma. Issue 2 (25th July 2012)

Authors:
Toh, Han Chong; Chen, Pei‐Jer; Carr, Brian I.; Knox, Jennifer J.; Gill, Sharlene; Ansell, Peter; McKeegan, Evelyn M.; Dowell, Barry; Pedersen, Michelle; Qin, Qin; Qian, Jiang; Scappaticci, Frank A.; Ricker, Justin L.; Carlson, Dawn M.; Yong, Wei Peng
Journal:
Cancer
Issue:
Volume 119:Issue 2(2013)
Page Start:
380
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib. Issue 2 (November 2015)

Authors:
McKeegan, Evelyn M.; Ansell, Peter J.; Davis, Gerard; Chan, Sabrina; Chandran, Raj K.; Gawel, Susan H.; Dowell, Barry L.; Bhathena, Anahita; Chakravartty, Arunava; McKee, Mark D.; Ricker, Justin L.; Carlson, Dawn M.; Ramalingam, Suresh S.; Devanarayan, Viswanath
Journal:
Lung cancer
Issue:
Volume 90:Issue 2(2015:Nov.)
Page Start:
296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search